Terran

Terran Biosciences announces new breakthroughs in the chemistry of MDMA and its enantiomers and analogs, discovers new salts and polymorphs, publishes PCT application.

Retrieved on: 
Friday, May 26, 2023
MDAI, Therapy, MEAI, PTSD, PCT, MDE, Literature, Patent, Post-traumatic stress disorder, Patient, USE, MBDB, Empathy, Terran, SALTS, MDMA, MDEA, Pharmaceutical industry

MDMA is the most studied empathogen to date and has been shown to be an effective treatment for post-traumatic stress disorder (PTSD) in multiple phase 3 trials.

Key Points: 
  • MDMA is the most studied empathogen to date and has been shown to be an effective treatment for post-traumatic stress disorder (PTSD) in multiple phase 3 trials.
  • Historically, MDMA has only been developed as a single salt and the crystal structures of its enantiomers had not been characterized.
  • As previously reported, Terran found that the S enantiomer of MDEA had significant advantages over the (R)-MDEA in preclinical models.
  • Terran is also developing the S enantiomer of MBDB which was shown to have significant advantages over (R)-MBDB in preclinical models.

Terran Biosciences discovers what may be the first new salts, co-crystals, and polymorphs of psilocybin in history, publishes PCT patent application, and files psilocybin Drug Master File (DMF) with FDA

Retrieved on: 
Friday, May 19, 2023
Psilocybin, GMP, Human, Drug Master File, Depression, Therapy, SOLID, History, PCT, Literature, Hydrogen chloride, Patent, Patient, DMF, Ecosystem, Salt, FDA, Terran, SALTS, Pharmaceutical industry

Psilocybin is one of the main active compounds in psychedelic mushrooms and has been used by humans for thousands of years.

Key Points: 
  • Psilocybin is one of the main active compounds in psychedelic mushrooms and has been used by humans for thousands of years.
  • Recent clinical studies suggest psilocybin is efficacious in treating depression.
  • According to the literature, there are three main polymorphic forms of zwitterionic psilocybin: form A, form B, and form A' (A-Prime).
  • Terran also replicated this comprehensive set of studies with the psilocin prodrug O-acetylpsilocin, resulting in additional novel salts and polymorphs of that compound as well.

Another Record: Terran Orbital-Developed PTD-3 Enables 200 Gigabits per Second Space-to-Ground Optical Link

Retrieved on: 
Friday, May 12, 2023
Satellite, Technology, Aerospace, Manufacturing, Other Technology, Software, Hardware, Orbital, Multimedia, MIT Lincoln Laboratory, Second, Space Communications and Navigation Program, NASA, LLAP, TBIRD, Terran, Byte, NYSE, Orbital Corporation, Communications satellite, Navigation

Terran Orbital Corporation (NYSE: LLAP ), (“Terran Orbital” or “the Company”), a global leader in satellite-based solutions primarily serving the aerospace and defense industries, today announced the Terran Orbital-developed Pathfinder Technology Demonstrator 3 (PTD-3) satellite enabled a successful 200 gigabits per second space-to-ground optical link.

Key Points: 
  • Terran Orbital Corporation (NYSE: LLAP ), (“Terran Orbital” or “the Company”), a global leader in satellite-based solutions primarily serving the aerospace and defense industries, today announced the Terran Orbital-developed Pathfinder Technology Demonstrator 3 (PTD-3) satellite enabled a successful 200 gigabits per second space-to-ground optical link.
  • View the full release here: https://www.businesswire.com/news/home/20230512005082/en/
    Terran Orbital-Developed PTD-3 Enables 200 Gigabits per Second Space-to-Ground Optical Link (Image Credit: NASA)
    With a transmission rate of multiple orders of magnitude faster than current state-of-the-art satellite communications, this technology enables spacecraft to downlink several terabytes of data to the ground in a single ground station pass.
  • The 200 gigabits per second space-to-ground optical link broke this record.
  • “The completion of the 200 gigabits per second link is both monumental and record-breaking,” said Terran Orbital Co-Founder, Chairman, and Chief Executive Officer Marc Bell.

Terran Biosciences announces publication of four PCT patent applications covering breakthroughs in novel empathogens, including improved versions of methylone, ethylone, MDEA, MDAI, and MBDB

Retrieved on: 
Thursday, May 11, 2023
MDMC, REMS, MDAI, Depression, Therapy, MDEA, Mitigation, Methylone, Anxiety, Therapeutic index, Pathology, Pharmacokinetics, PCT, MDE, DSM-IV codes, Literature, OF, Patent, Patient, Post-traumatic stress disorder, USE, MBDB, Empathy, Salt, SALTS, MDMA, Safety, Pharmaceutical industry, Vaccine, Terran, PTSD

The discoveries include novel deuterated forms, enantiomerically pure forms, as well as novel salts, polymorphs, and co-crystals of racemic methylone, R-methylone and S-methylone.

Key Points: 
  • The discoveries include novel deuterated forms, enantiomerically pure forms, as well as novel salts, polymorphs, and co-crystals of racemic methylone, R-methylone and S-methylone.
  • Terran believes that therapeutic options for patients should be equally diverse, with unique psychedelics and empathogens tailored to specific patient needs.
  • Terran completed what is believed to be the first comprehensive salt and polymorph screen performed to date on this compound.
  • Terran completed additional improvements including the synthesis of deuterated forms of racemic methylone, R-methylone, and S-methylone with improved pharmacokinetics.

Terran Orbital Receives Milestone Payment for 300 Spacecraft, $2.4 Billion Contract with Rivada Space Networks

Retrieved on: 
Thursday, April 27, 2023
Other Transport, Aerospace, IOT (Internet of Things), Government Technology, Manufacturing, Satellite, Defense, Transport, Other Technology, Telecommunications, Other Defense, Networks, Internet, Hardware, Electronic Design Automation, Data Management, Technology, Mobile, Wireless, Communication, Orbital, Multimedia, RSN, Acquisition, LEO, Pleasure, LLAP, Orbital Corporation, Terran, Ganley, NYSE, Automation, Tyvak, Communications satellite, Spacecraft

Terran Orbital Corporation (NYSE: LLAP ) (“Terran Orbital” or “the Company”), a global leader in satellite-based solutions, today announced the receipt of a further milestone payment alongside completion of the screening of the industrial partners as well as trade studies that will support the acquisition process and system engineering for the Company’s 300 spacecraft, $2.4 billion contract with Rivada Space Networks.

Key Points: 
  • Terran Orbital Corporation (NYSE: LLAP ) (“Terran Orbital” or “the Company”), a global leader in satellite-based solutions, today announced the receipt of a further milestone payment alongside completion of the screening of the industrial partners as well as trade studies that will support the acquisition process and system engineering for the Company’s 300 spacecraft, $2.4 billion contract with Rivada Space Networks.
  • View the full release here: https://www.businesswire.com/news/home/20230427005223/en/
    Terran Orbital Receives Milestone Payment for 300 Spacecraft, $2.4 Billion Contract with Rivada Space Networks (Image Credit: Rivada)
    Terran Orbital, through its wholly owned subsidiary Tyvak Nano-Satellite Systems, Inc. (“Tyvak”), will design, build, and deploy 288 low-Earth orbit satellites and 12 “spare” satellites to produce a total of 300 spacecraft weighing approximately 500 kg a piece.
  • Terran Orbital will also integrate the communication payload and perform the final satellite assembly, integration, and test.
  • “Working with Rivada has been a pleasure,” said Terran Orbital Co-Founder, Chairman, and Chief Executive Officer Marc Bell.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Terran Orbital, Inc. - LLAP

Retrieved on: 
Sunday, April 16, 2023
Tripura Merger Agreement, Mergers and acquisitions, LLAP, Terran, NYSE, Private investigator

NEW YORK, April 16, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Terran Orbital, Inc. (“Terran” or the “Company”) (NYSE: LLAP).

Key Points: 
  • NEW YORK, April 16, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Terran Orbital, Inc. (“Terran” or the “Company”) (NYSE: LLAP).
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether Terran and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Terran Orbital, Inc. – LLAP

Retrieved on: 
Saturday, April 8, 2023
Tripura Merger Agreement, Mergers and acquisitions, LLAP, Terran, NYSE, Private investigator

NEW YORK, April 08, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Terran Orbital, Inc. (“Terran” or the “Company”) (NYSE: LLAP).

Key Points: 
  • NEW YORK, April 08, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Terran Orbital, Inc. (“Terran” or the “Company”) (NYSE: LLAP).
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether Terran and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions.

Relativity Space Shares Updated Go-to-Market Approach for Terran R, Taking Aim at Medium-to-Heavy Payload Category with Next-Generation Rocket

Retrieved on: 
Wednesday, April 12, 2023
Engineering, Technology, Satellite, Aerospace, Manufacturing, Hardware, Transfer, Autumn, Relativity Space, Vacuum, Perseverance, Reaction control system, PAF, Travel, Geostationary transfer orbit, MEO, Terran 1, Homebase, Friends, TVC, OneWeb, 3D, Panama, Orbit, Spacecraft, RS, Multimedia, LSA, Terran R, TCA, RCS, Government, Liquid oxygen, Vandenberg Space Force Base, EMA, Aeon, Public service agreement, Relativity, GEO, EMAS, MECO, LEO, Horizontal, Architecture, Methane, Heat, Fear of negative evaluation, Total, 3D printing, Communications satellite, Iridium, Mars, Moon, Terran

Starting in 2026, Terran R will launch from Space Launch Complex 16, the company’s orbital launch site at Cape Canaveral, Florida.

Key Points: 
  • Starting in 2026, Terran R will launch from Space Launch Complex 16, the company’s orbital launch site at Cape Canaveral, Florida.
  • Each Terran R requires approximately 6 times more 3D printing by mass than Terran 1.
  • Initially, Terran R will use the same proprietary printed aluminum alloy as flown on Terran 1 with a focus on supply chain scaling.
  • Terran R’s first stage will be outfitted with 13 3D-printed gas generator cycle Aeon R LOx/Methane rocket engines each capable of 258,000 lb.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Terran Orbital, Inc. - LLAP

Retrieved on: 
Thursday, March 30, 2023
Tripura Merger Agreement, Mergers and acquisitions, LLAP, Terran, NYSE, Private investigator

NEW YORK, March 29, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Terran Orbital, Inc. (“Terran” or the “Company”) (NYSE: LLAP).

Key Points: 
  • NEW YORK, March 29, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Terran Orbital, Inc. (“Terran” or the “Company”) (NYSE: LLAP).
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether Terran and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Terran Orbital, Inc. - LLAP

Retrieved on: 
Monday, March 20, 2023
Tripura Merger Agreement, Mergers and acquisitions, LLAP, Terran, NYSE, Private investigator

NEW YORK, March 20, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Terran Orbital, Inc. (“Terran” or the “Company”) (NYSE: LLAP).

Key Points: 
  • NEW YORK, March 20, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Terran Orbital, Inc. (“Terran” or the “Company”) (NYSE: LLAP).
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether Terran and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions.